<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>3942</number>
    <updateDate>2023-01-11T13:46:15Z</updateDate>
    <updateDateIncludingText>2023-01-11T13:46:15Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <type>S</type>
    <introducedDate>2020-06-11</introducedDate>
    <congress>116</congress>
    <committees>
      <item>
        <systemCode>ssfi00</systemCode>
        <name>Finance Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2020-06-11T17:23:36Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Lower Costs, More Cures Act of 2019</title>
        <congress>116</congress>
        <number>19</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-12-19</actionDate>
          <text>Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Fixing Global Freeloading Act</title>
        <congress>116</congress>
        <number>2209</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-04-10</actionDate>
          <text>Referred to the Subcommittee on Trade.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Competition Prescription Act of 2019</title>
        <congress>116</congress>
        <number>3947</number>
        <type>HR</type>
        <latestAction>
          <actionDate>2019-08-28</actionDate>
          <text>Referred to the Subcommittee on the Constitution, Civil Rights, and Civil Liberties.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
      <item>
        <title>Lower Costs, More Cures Act of 2019</title>
        <congress>116</congress>
        <number>3129</number>
        <type>S</type>
        <latestAction>
          <actionDate>2019-12-19</actionDate>
          <text>Read twice and referred to the Committee on Finance.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2020-06-11</actionDate>
        <committees>
          <item>
            <systemCode>ssfi00</systemCode>
            <name>Finance Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Finance.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2020-06-11</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>L000594</bioguideId>
        <fullName>Sen. Loeffler, Kelly [R-GA]</fullName>
        <firstName>Kelly</firstName>
        <lastName>Loeffler</lastName>
        <party>R</party>
        <state>GA</state>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <policyArea>
      <name>Foreign Trade and International Finance</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Competitiveness, trade promotion, trade deficits</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Executive agency funding and structure</name>
        </item>
        <item>
          <name>Federal officials</name>
        </item>
        <item>
          <name>Government employee pay, benefits, personnel management</name>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
        </item>
        <item>
          <name>Office of the U.S. Trade Representative</name>
        </item>
        <item>
          <name>Prescription drugs</name>
        </item>
        <item>
          <name>Trade agreements and negotiations</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Foreign Trade and International Finance</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2020-06-11</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2020-12-30T21:24:08Z</updateDate>
        <text><![CDATA[ <p><b>Securing America's Medical Supply Chain and Advancing the Production of Life Saving Medicines Act </b></p> <p>This bill establishes the position of Chief Pharmaceutical and Medical Supply Chain Negotiator in the Office of the U.S. Trade Representative. The negotiator must conduct trade negotiations and enforce trade agreements related to pharmaceutical products and services and medical supply chains. </p>]]></text>
      </summary>
    </summaries>
    <title>Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act</title>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Securing America’s Medical Supply Chain and Advancing the Production of Life Saving Medicines Act</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>A bill to establish the position of Chief Pharmaceutical and Medical Supply Chain Negotiator in the Office of the United States Trade Representative, to be responsible for conducting trade negotiations and enforcing trade agreements related to acts, policies, and practices of foreign governments that fail to appropriately reward United States innovation with respect to pharmaceuticals, to advance domestic production of life-saving medicines, and to secure the United States medical supply chain to eliminate reliance on foreign governments, and for other purposes.</title>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2020-06-11T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-116s3942is/xml/BILLS-116s3942is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2020-06-11</actionDate>
      <text>Read twice and referred to the Committee on Finance.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
